Table 1.
Clinical characteristics of the study population
| Parameter | Value for the group |
||
|---|---|---|---|
| T1D (n= 30) | LADA (n= 43) | Control (n= 75) | |
| Median age (yrs) | 21.06 ± 3.69 | 39.57 ± 4.68 | 30 ± 7.9 |
| Median age at diagnosis (yrs) | 18.06 ± 3.87 | 26.32 ± 1.90 | |
| Median duration of diabetes (yrs) | 2.6 ± 4.87 | 3.90 ± 3.23 | |
| Insulin dose (μU/ml) | 16.61 ± 3.55 | 13.39 ± 3.76 | 7.78 ± 1.55 |
| C peptide (ng/ml) | 0.61 ± 0.06 | 0.98 ± 0.24 | 1.57 ± 0.34 |
| Hemoglobin A1c (%) | 8.23 ± 1.26 | 8.5 ± 2.01 | 6 ± 1.006 |
| BMI (kg/m2)a | 22 ± 6.8 | 25.98 ± 5.62 | 25.98 ± 5.62 |
a
BMI, body mass index.